Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Edition
European
US
Oncology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
TNBC Study Identifies Drug Resistant Cell States
May 2026
Researchers identified persistent drug tolerant cell states in TNBC that survive chemotherapy and may drive metastatic progression and treatment resistance.
Read more
5 Dec 2025
Targeted Drug Shows Promise in Aggressive Pancreatic Cancer
Garsorasib shrank tumours in nearly half of patients with KRAS G12C pancreatic cancer and showed manageable side effects.
3 Dec 2025
Engineered Virus Shows New Hope Against Deadly Brain Cancer
Engineered herpes virus targets glioblastoma cells, destroying tumours while activating immune defences in preclinical brain cancer models.
2 Dec 2025
Single-Fraction Radiotherapy Shows Promise in Early Breast Cancer
Phase 1 trial shows single-fraction stereotactic breast irradiation is safe and effective
12 Nov 2025
Genomic Profiling Guides Targeted Treatment in Advanced Prostate Cancer
Genomic profiling revealed druggable targets in 39% of advanced prostate cancer cases, guiding personalised treatments.
10 Nov 2025
Risk-Based Screening Improves Skin Cancer Detection After Transplant
A targeted screening programme improved early skin cancer detection in transplant recipients without increasing healthcare demands.
8 Nov 2025
Tamoxifen Linked to Lasting Hair Loss After Chemotherapy
Tamoxifen treatment may reduce the effectiveness of scalp cooling, leading to persistent hair loss after chemotherapy.
28 Oct 2025
AI Framework Revolutionises Brain Tumour Detection
DenseWolf-K, a hybrid AI framework, achieved 99.64% accuracy in brain tumour MRI classification, revolutionising medical imaging.
27 Oct 2025
Nivolumab’s Lasting Edge Confirmed in Melanoma Trial
Nivolumab shows lasting melanoma recurrence prevention, with long-term safety, in largest-ever CheckMate 238 trial analysis.
Loading posts...
« Previous
1
…
8
9
10
11
12
…
66
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View